Can I please get some clarity on some of what youve said in your last two posts.
So 2024 is a big time frame. Someone with your experience would have some idea even with the factors out of your control. When will we find out more about when the first patient will be dosed? Im getting the impression by your vague response to index that it's not necessarily going to kick off straight after we receive RC220 tox report mid year. Would I be right in assuming first patient is more likely dosed late Q4?
You said, "We will have clinical data before the end of the year, not least because the Sheba 2 trial is still running.". Best to leave Sheba 2 RC110 out of the equation as its old kingdom and its relevance to pivoting the SP is 0. Im hoping when you say we will have data you are referring to the all-comers trail. It's only going to take RACE dosing 1 patient in the all-comers trial for your answer to be technically correct. My Q is: Will the market be updated via an ASX ann in 2024 on results from the all-comers trial?
Ann: Race global agreement with City of Hope to access FTO IP, page-252
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
0.040(3.28%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.27 | $1.19 | $119.8K | 97.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1526 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 1986 | 1 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
0.040 ( 2.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.22 | $1.27 | $1.20 | 20698 | ||
| Last updated 15.58pm 08/05/2024 ? | |||||
| RAC (ASX) Chart |